| Literature DB >> 35735572 |
Sayed M Saleh1,2, Wael A El-Sayed1,3, May A El-Manawaty4, Malek Gassoumi5,6, Reham Ali1,7.
Abstract
A new preparation method for extreme fluorescent green emission tryptophan-stabilized silver nanoclusters (Tryp-AgNCs) is presented in this scientific research. The produced silver nanoclusters are dependent on tryptophan amino acid which contributes to normal growth in infants and the sublimation and recovery of human protein, muscles, and enzymes. Herein, we have introduced a green method by using microwave-assisted rapid synthesis. The subsequent silver nanoclusters (AgNCs) have excitation/emission peaks at 408/498 nm and display a considerable selectivity to Fe(III) ions. The tryptophan amino acid molecule was used in the synthesis process as a reducing and stabilizing agent. The Tryp-AgNCs' properties were investigated in terms of morphology, dispersity, and modification of the synthesized particles using different advanced instruments. The luminescent nanoclusters traced the Fe(III) ions by the luminescence-quenching mechanism of the Tryp-AgNCs luminescence. Therefore, the extreme selectivity of the prepared nanoclusters was exhibited to the Fe(III) ions, permitting the sensitive tracing of ferric ions in the lab and in the real environmental samples. The limit of detection for Fe(III) ions based on Tryp-AgNCs was calculated to be 16.99 nM. The Tryp-AgNCs can be efficiently applied to a paper test strip method. The synthesized nanoclusters were used efficiently to detect the Fe(III) ions in the environmental samples. Moreover, we examined the reactivity of Tryp-AgNCs on various human tumor cell lines. The results show that the Tryp-AgNCs exhibited their activity versus the cancer cells in a dose-dependent routine for the perceived performance versus the greatest-used cancer cell lines.Entities:
Keywords: Fe(III); anticancer; green synthesis; sensing; silver nanoclusters; tryptophan
Mesh:
Substances:
Year: 2022 PMID: 35735572 PMCID: PMC9220979 DOI: 10.3390/bios12060425
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Scheme 1The synthesis scheme of Tryp-AgNCs and their use in Fe(III) ions tracing.
Figure 1(a) The absorption spectra of the tryptophan and Tryp-AgNCs; (b) The excitation and emission spectra of Tryp-AgNCs.
Figure 2(a,b) TEM images; (c) DLS; and (d) SD histogram of the as-prepared Tryp-AgNCs.
Figure 3(a) FTIR spectra of tryptophan; (b) Tryp-AgNCs.
Figure 4(a) XPS spectra of Ag3d for AgNCs; (b) The whole XPS spectrum of AgNCs.
Figure 5(a) Fluorescence emission of Tryp-AgNCs in the presence of a various concentration of Fe(III) ions from 0.1 to 6 mM; (b) Classical Stern–Volmer plot of fluorescence intensities ratio versus the quencher concentrations.
Figure 6DLS data of Tryp-AgNCs in the presence of (a) 0.05; (b) 1.5; (c) 3.0; and (d) 6.0 μM Fe(III).
Figure 7(a) Tryp-AgNCs fluorescence intensities in the presence of (I) each different metal ions and (II) each different metal ions and Fe(III); (b) The recovery effect of EDTA solution on Tryp-AgNCs fluorescence.
Scheme 2Test strips application-based Tryp-AgNCs for tracing Fe(III).
Tracing of Fe(III) in real samples depending on Tryp-AgNCs (n = 3).
| Samples | Added | ICP-MS | Found | RSD | Recovery |
|---|---|---|---|---|---|
| Mineral water | 0.50 | 0.509 | 0.488 | 1.24 | 97.60 |
| 2.00 | 2.006 | 1.987 | 0.91 | 99.35 | |
| 3.50 | 3.497 | 3.484 | 0.87 | 99.54 | |
| Tap water | 0.50 | 0.517 | 0.483 | 1.32 | 96.60 |
| 2.00 | 2.009 | 1.981 | 0.94 | 99.05 | |
| 3.50 | 3.505 | 3.489 | 0.92 | 99.68 |
Recent optical sensors for ferric ions’ detection.
| Synthesis Agent | Type of NPs | Fluorescence Mechanism | Dynamic Range (µM) | LOD | Refs. |
|---|---|---|---|---|---|
| Peptide-6 (GHRP-6) | Au-NCs | Turn-off | 2–1000 | 1.4 | [ |
| Prunus avium fruit extract | Carbon Dot | Turn-off | 0–100 | 0.96 | [ |
| Vancomycin | Au-NCs | Turn-off | 2–100 | 1.4 | [ |
| Fish-scale | Carbon dot | Turn-off | 1–78 | 0.54 | [ |
| l-proline | Au-NCs | Turn-off | 5–2000 | 2.0 | [ |
| Boron | Carbon Dot | Turn-off | 0−16 | 242 | [ |
| l-3,4-dihydroxyphenylalanine | Au-NCs | Turn-off | 5–1280 | 3.5 | [ |
| Glutathione | Ag-NCs | Turn-off | 0.5–2 | 0.12 | [ |
| Tryptophan | Ag-NCs | Turn-off | 0–6 | 0.0169 | This work |
The activity of Tryp-AgNCs on tumor cell lines.
| Cell | 100 µM | 50 µM | 25 µM | 12.5 µM |
|---|---|---|---|---|
| HOS | 75.6 ± 5.7 | 28.2 ± 5.0 | 22.7 ± 2.2 | 0.0 ± 0.0 |
| MCF7 | 95.7 ± 0.3 | 55.7 ± 3.2 | 32.9 ± 1.2 | 5.4 ± 1.0 |
| PC3 | 54.6 ± 11.5 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| A549 | 36.5 ± 0.9 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| A431 | 67.7 ± 6.1 | 3.9 ± 0.5 | 14.1 ± 0.5 | 8.2 ± 0.8 |
| HCT116 | 10.9 ± 11.3 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| PaCaII | 67.9 ± 8.9 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
| RPE1 | 14.6 ±1.2 | 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 |
Figure 8The activity of Tryp-AgNCs on the different tumor cell lines.
IC50 (µM) of Ag-Try on human tumor cell lines.
| Cell | IC50 |
|---|---|
| MCF7 | 39.2 ± 5.5, r2 = 0.95 |
| HOS | 66.3 ± 13.3, r2 = 0.89 |
| A431 | 87.8 ± 1, r2 = 0.99 |